Dr. Ira Dunkel, MD

NPI: 1003887746
Total Payments
$60,181
2024 Payments
$12,935
Companies
7
Transactions
37

Payment Breakdown by Category

Consulting$48,478 (80.6%)
Travel$10,894 (18.1%)
Research$565.00 (0.9%)
Food & Beverage$243.84 (0.4%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $48,478 21 80.6%
Travel and Lodging $10,894 9 18.1%
Unspecified $565.00 1 0.9%
Food and Beverage $243.84 6 0.4%

Payments by Type

General
$59,616
36 transactions
Research
$565.00
1 transactions

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $29,052 11 $0 (2024)
F. Hoffmann-La Roche AG $13,726 5 $0 (2019)
AstraZeneca UK Limited $6,738 11 $0 (2024)
Celgene Corporation $4,973 7 $0 (2022)
GlaxoSmithKline, LLC. $3,900 1 $0 (2022)
E.R. Squibb & Sons, L.L.C. $1,725 1 $0 (2020)
Novartis Pharmaceuticals Corporation $66.82 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $12,935 4 AstraZeneca Pharmaceuticals LP ($8,825)
2023 $4,650 3 AstraZeneca Pharmaceuticals LP ($4,650)
2022 $5,835 3 GlaxoSmithKline, LLC. ($3,900)
2021 $2,740 1 AstraZeneca Pharmaceuticals LP ($2,740)
2020 $16,053 15 AstraZeneca Pharmaceuticals LP ($12,837)
2019 $14,076 6 F. Hoffmann-La Roche AG ($13,726)
2018 $1,642 4 Celgene Corporation ($1,575)
2017 $2,250 1 Celgene Corporation ($2,250)

All Payment Transactions

37 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/09/2024 AstraZeneca UK Limited Truqap (Drug) Consulting Fee Cash or cash equivalent $4,110.00 General
Category: Oncology
06/03/2024 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $3,425.00 General
05/06/2024 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $3,000.00 General
03/14/2024 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $2,400.00 General
07/18/2023 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $300.00 General
04/27/2023 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $1,650.00 General
02/02/2023 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $2,700.00 General
12/07/2022 GlaxoSmithKline, LLC. Consulting Fee Cash or cash equivalent $3,900.00 General
07/20/2022 Celgene Corporation Cash or cash equivalent $565.00 Research
Study: CC-4047-BRN-001 (Ped MonoTx)
03/01/2022 AstraZeneca UK Limited KOSELUGO (Drug) Consulting Fee Cash or cash equivalent $1,370.00 General
Category: Oncology
09/21/2021 AstraZeneca Pharmaceuticals LP KOSELUGO (Drug) Consulting Fee Cash or cash equivalent $2,740.00 General
Category: Oncology
11/25/2020 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $7,950.00 General
07/22/2020 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $1,725.00 General
05/27/2020 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $600.00 General
03/05/2020 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $4,200.00 General
03/05/2020 AstraZeneca Pharmaceuticals LP Travel and Lodging Cash or cash equivalent $87.27 General
02/03/2020 AstraZeneca UK Limited Travel and Lodging In-kind items and services $305.45 General
02/03/2020 AstraZeneca UK Limited Travel and Lodging In-kind items and services $269.30 General
02/03/2020 AstraZeneca UK Limited Travel and Lodging In-kind items and services $255.49 General
02/03/2020 AstraZeneca UK Limited Travel and Lodging In-kind items and services $199.94 General
02/03/2020 AstraZeneca UK Limited Travel and Lodging In-kind items and services $132.00 General
02/03/2020 AstraZeneca UK Limited Food and Beverage In-kind items and services $52.35 General
02/03/2020 AstraZeneca UK Limited Food and Beverage In-kind items and services $17.39 General
02/03/2020 AstraZeneca UK Limited Food and Beverage In-kind items and services $15.41 General
02/03/2020 AstraZeneca UK Limited Food and Beverage In-kind items and services $10.43 General

Research Studies & Clinical Trials

Study Name Company Amount Records
CC-4047-BRN-001 (Ped MonoTx) Celgene Corporation $565.00 1

About Dr. Ira Dunkel, MD

Dr. Ira Dunkel, MD is a Pediatric Hematology-Oncology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003887746.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ira Dunkel, MD has received a total of $60,181 in payments from pharmaceutical and medical device companies, with $12,935 received in 2024. These payments were reported across 37 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($48,478).

Practice Information

  • Specialty Pediatric Hematology-Oncology
  • Location New York, NY
  • Active Since 01/31/2006
  • Last Updated 04/25/2012
  • Taxonomy Code 2080P0207X
  • Entity Type Individual
  • NPI Number 1003887746

Products in Payments

  • COTELLIC (Drug) $13,726
  • KOSELUGO (Drug) $4,110
  • Truqap (Drug) $4,110
  • Pomalyst (Drug) $350.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Hematology-Oncology Doctors in New York